Restoring Sight

https://agnostx.com/

Last activity: 08.07.2026

Active

Categories: Human

Agnos Therapeutics is developing AGN-001, a mutation-agnostic iPSC retinal cell therapy to restore vision for inherited blindness.

Investors 1

Date	Name	Website
08.07.2026	Retinal De...	retinaldeg...

Sign up to leave a review

Sign up Log In